News

Read the latest news about issues affecting the neuromuscular disease community.

Blog Post

Clinical Study Alert: A Phase 1/2 Study of Safety and Efficacy of LX2006 Gene Therapy in Adults with Cardiomyopathy Associated with Friedreich Ataxia

By Sujatha Gurunathan | March 25, 2024
Blog Post

FDA’s Approval of Duvyzat (givinostat) Offers New Hope to People Living with Duchenne Muscular Dystrophy

By MDA Staff | March 21, 2024
Blog Post

At MDA Conference Neuromuscular Disease Experts Discuss Readiness for Gene Therapies

By Larry Luxner | March 20, 2024
Blog Post

Heart of the Muscular Dystrophy Association Mission Was in Focus at the 2024 MDA Clinical & Scientific Conference Opening Day

By Amy Bernstein | March 5, 2024
Photograph of a girl in a graduation gown kneeling next to a golden retriever in a cap and gown, round blue graphic next to image that says "Apply Today, MDA COLLEGE SCHOLARSHIP" and lists website
Blog Post

MDA Announces College Scholarship Program

By MDA Staff | February 27, 2024
Blog Post

Inclusion Outshines Ableism on the Big Stage

By Rebecca Hume | February 26, 2024
Collage image with six photos of various MDA events and supported research
Blog Post

2023 in Review: A Letter from MDA President and CEO, Dr. Wood

By Donald S. Wood, Ph.D., President and CEO, Muscular Dystrophy Association | December 11, 2023
wooden blocks spell out the word content with word bubbles above that say news and stories and photos and blog
Blog Post

In Case You Missed It…

By MDA Staff | November 8, 2023
Blog Post

AGAMREE ® (Vamorolone), Now FDA-Approved, Offers Hope for Children Living with Duchenne Muscular Dystrophy

By MDA Staff | October 26, 2023
Blog Post

Quest Media’s Inclusive Holiday Product Guide

By Mindy Henderson | October 22, 2023